Related Experiment Video

Updated: May 16, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Improving T-cell therapy for epstein-barr virus lymphoproliferative disorders

Catherine M Bollard

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |November 22, 2012
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection09:43

    An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

    Published on: March 30, 2018

    Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines06:38

    Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

    Published on: November 8, 2011

    Related Concept Videos

    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.